Reevaluating Beta-Blockers: Are They Still Beneficial for Heart Patients?
TL;DR
A large international study called the REBOOT trial has found that beta blockers, a common treatment for heart attack survivors with normal heart function, do not provide benefits and may increase risks for women, challenging decades of standard practice.
- After 40 Years, Heart Doctors Say Beta Blockers May Do More Harm Than Good SciTechDaily
- Common heart attack drug doesn’t work and may raise risk of death for some women, new studies say CNN
- Beta-Blockers Post-MI: A Clear Clinical Message Medscape
- Heart attack: Common pill may not be helpful in all cases MedicalNewsToday
- A Common Heart Drug Taken by Millions May Often Be Useless – or Even Risky ScienceAlert
Want the full story? Read the original reporting
Read on SciTechDaily